NCT02182635View on ClinicalTrials.gov

Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

March 31, 1999

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Ba253BINEB

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02182635 - Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter